Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis

Clinica Chimica Acta

Volumn 411, Issue 1-2, 2010, Pages 31-36

  Boot, Rolf G ^a   Hollak, Carla E M ^a   Verhoek, Marri ^a   Alberts, C ^a   Jonkers, René E ^a   Aerts, Johannes M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

CCL18; Chitotriosidase; Macrophages; Plasma; Sarcoidosis

Indexed keywords

CCL18 CHEMOKINE; CHEMOKINE; CHITOTRIOSIDASE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; GRANULOMATOSIS; HUMAN; IN SITU HYBRIDIZATION; LABORATORY TEST; MACROPHAGE ACTIVATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELAPSE; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES, CC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEXOSAMINIDASES; HUMANS; IN SITU HYBRIDIZATION; MACROPHAGES; MALE; MIDDLE AGED; MURAMIDASE; PEPTIDYL-DIPEPTIDASE A; SARCOIDOSIS;

EID: 70449535514     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.09.034     Document Type: Article

References (40)

1. Thomas K.W., and Hunninghake G.W. Sarcoidosis. JAMA 289 (2003) 3300-3303
2. Reich J.M. Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity and corticosteroid therapy. Chest 121 (2002) 32-39
3. DeRemee R.A. Sarcoidosis. Mayo Clin Proc 70 (1995) 177-181
4. Müller-Quernheim J. Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung disease of unknown etiology. Sarcoidosis Vasc Diffuse Lung Dis 15 (1998) 22-37
5. Ziegenhagen M.W., and Müller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 253 (2003) 18-30
6. Ziegenhagen M.W., Rothe M.E., Schlaak M., and Müller-Quernhem J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 21 (2003) 407-413
7. Sharma O.P. Markers of sarcoidosis activity. Chest 90 (1986) 471-473
8. Shigehara K., Shijubo N., Ohmici M., et al. N. Increased circulating interleukin 12 p40 in pulmonary sarcoidosis. Clin Exp Immunol 132 (2003) 152-157
9. Capelli A., Di Stefano A., Lusuardi M., Gnemmi I., and Donner C.F. Increased macrophage inflammatory protein-1α and macrophage inflammatory protein-1β levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis. Am J Respir Crit Care Med 165 (2002) 236-241
10. Muthuswamy P.P., Lopez-Majano V., Panginwala M., and Trainor W.D. Serum angiotensin-converting enzyme as an indicator of total body granuloma load and prognosis in sarcoidosis. Sarcoidosis 4 (1987) 142-148
11. Turner-Warwick M., McAllister W., Lawrence R., Britten A., and Haslam P.L. Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin-converting enzyme measurements and gallium-67 scans help management?. Thorax 41 (1986) 903-913
12. Baughman R.P., Lower E.E., and du Bois R.M. Sarcoidosis. Lancet 361 (2003) 1111-1118
13. Beutler E., and Grabowski G. Gaucher disease. In: Scriver C.R., Sly W.S., and Valle D. (Eds). The metabolic basis of inherited disease (1995), Mc Graw-Hill, New York 2641-2670
14. Aerts J.M., Hollak C., Boot R., and Groener A. Biochemistry of glycosphingolipids storage disorders: implications for therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 358 (2003) 905-914
15. Hollak C.E., van Weely S., van Oers M.H., and Aerts J.M. Elevated plasma chitotriosidase: a novel biochemical hallmark of Gaucher disease. J Clin Invest 93 (1994) 1288-1292
16. Aerts J.M., and Hollak C.E. Plasma and metabolic abnormalities in Gaucher's disease. Baillieres Clin Haematol 10 (1997) 691-709
17. Aguilera B., Ghauharali-Van Der Vlugt K., Helmond M.T., et al. Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase. J Biol Chem 278 (2003) 40911-40916
18. Boven L.A., van Meurs M., Boot R.G., et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol 122 (2004) 359-369
19. Boot R.G., Verhoek M., De Fost M., et al. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 103 (2004) 33-39
20. Deegan P.B., Moran M.T., McFarlane I., et al. Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. Blood Cells Mol Diseases 35 (2005) 259-267
21. Boot R.G., Renkema G.H., Verhoek M., et al. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem 273 (1998) 25680-25685
22. Homalka J., Lorenz J., Zuchold H.D., and Müller-Quernheim J. Evaluation of soluble CD14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis. Clin Invest 70 (1992) 909-916
23. Mörsky P. Turbidimetric determination of lysozyme with micrococcus lysodeikticus cells: reexamination of reaction conditions. Anal Biochem 128 (1983) 77-85
24. Brunner J., Scholl-Burgi S., Prelog M., and Zimmerhackl L.B. Chitotriosidase as a marker of disease activity in sarcoidosis. Rheumatol Int 27 (2007) 1185-1186
25. Grosso S., Margollicci M.A., Bargagli E., et al. Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Scand J Clin Lab Invest 64 (2004) 57-62
26. Bargagli E., Bianchi N., Margollicci M., et al. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity. Scand J Clin Lab Invest 68 (2008) 479-483
27. Bargagli E., Maggiorelli C., and Rottoli P. Human chitotriosidase: a potential new marker of sarcoidosis severity. Respiration 76 (2008) 234-238
28. Rennard S., Basset G., Lecossier D., O'Donnell K., Martin P., and Crystal R.G. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. Appl Physiol 60 (1986) 532-538
29. Boot R.G., Achterberg T.A., van Aken B.E., et al. Strong induction of members of the chitinase family of proteins in artherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscl Thromb Vasc Biol 19 (1999) 687-694
30. Mrazek F., Sekerova V., Drabek J., Kolek V., du Bois R.M., and Petrek M. Expression of the chemokine PARC mRNA in bronchoalveolar cells of patients with sarcoidosis. Immunol Lett 84 (2002) 17-22
31. Johansen J.S., Milman N., Hansen M., Garbarsch C., Price P.A., and Graudal N. Increased serum YKL-40 in patients with pulmonary sarcoidosis-a potential marker of disease activity?. Respir Med 99 (2005) 396-402
32. Kruit A., Grutters J.C., Ruven H.J., van Moorsel C.C., and van den Bosch J.M. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir Med 101 (2007) 1563-1571
33. Reape T.J., Rayner K., Manning C.D., et al. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am J Pathol 154 (1999) 365-374
34. Schutyser E., Struyf S., Wuyts A., et al. Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis. Eur J Immunol 31 (2001) 3755-3762
35. Barone R., Di Gregorio F., Romeo M.A., Schiliro G., and Pavone L. Plasma chitotriosidase activity in patients with beta-thalassemia. Blood Cells Mol Diseases 25 (1999) 1-8
36. Dimitriou E., Verhoek M., Altun S., et al. Elevated plasma chemokine CCL18/PARC in beta-thalassemia. Blood Cells Mol Diseases 35 (2005) 328-331
37. Brinkman J., Wijburg F.A., Hollak C.E., et al. Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease. J Inherit Metab Dis 28 (2005) 13-20
38. Guo Y., He W., Boer A.M., et al. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis 18 (1995) 717-722
39. Mantovani A., Sozzani S., Locati M., Allavena P., and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23 (2002) 549-555
40. Günther A., Schmidt R., Nix F., et al. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J 14 (1999) 565-573